Dr George Follows discusses the role of CLL pa... - CLL Support

CLL Support

22,367 members38,474 posts

Dr George Follows discusses the role of CLL patients with oral therapies and new medicines.

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin
2 Replies

In this next video from Dr follows; the importance of compliance with taking maintenance medication is discussed and how this is now coming to CLL with the new targeted non chemo therapies '

The new targeted therapies will require discipline and engagement by patients to ensure they take their medications to stay in remission. Longer term the research community is working towards novel none chemo combinations that may produce a durable MRD status, removing the need then for continued medication, this could one day translate into a cure.

Q1) What would you say is the CLL patient’s role and responsibility when it comes to their treatment?

Q2) Do you think we could ever get to the point where patients can stop taking medicines after treatment?

youtube.com/watch?v=EJbubDu...

Written by
HAIRBEAR_UK profile image
HAIRBEAR_UK
Founder Admin
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Graham2222 profile image
Graham2222

I do appreciate this positive, research-informed, future-focused approach. Thank you.

jangreen profile image
jangreen

Hi Many thanks for these videos as I find them really helpful.Best wishes

You may also like...

Dr George Follows and your CLL questions

Dear CLL friends: I am so excited that ASH is in my new home city, San Diego later this week. And I...

Dr Michael Keating's Story - Taking CLL Therapies From Bedside to Community

com/publications/Oncology-live/2019/vol-20-no-21/taking-cll-therapies-from-bedside-to-community...

Dr. O'Brien on how she treats CLL frontline and Dr. Pagel on new ways to block BTK

decides what is the best front line treatment option for her CLL patients....

An Early Look at When CAR-T Therapy Fails Patients With CLL

happens in the patients for whom CAR-T therapy does not work,” “Anecdotally, we say that patients...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

and I discuss the role and the politics of the underuse of radioimmune therapy in CLL. It is worth...